Cardionomic
is a biotechnology company that develops catheter-based neuromodulation therapy for the treatment of ADHF... Read moreCardionomic
is a biotechnology company that develops catheter-based neuromodulation therapy for the treatment of ADHF... Read more
News
Jan 03, 2024
Newswise
Press Release: Cardionomic : Cardionomic Announces Enrollment Completion in the STIM-ADHF and STOP-ADHF Pilot Studies
May 19, 2022
Markets Insider
Cardionomic: Cardionomic Announces First Patient Enrolled in STIM-ADHF Study
May 16, 2022
Markets Insider
Cardionomic: Pulse Technologies' Electrode Surface Treatment Chosen for Cardiac Device
Nov 02, 2021
Medical Device News Magazine
Cardionomic: 1st U.S. Patient Enrolled in Cardionomic's CPNS System Pilot Study
Apr 15, 2021
MarketScreener
Cardionomic: Cardionomic Announces First Patients Enrolled in CPNS Pilot Study
Feb 07, 2020
SEC
Cardionomic: Cardionomic received $15.8M in Equity Funding
Oct 27, 2015
FINSMEs
Cardionomic: Cardionomic Receives $20M in Series A Financing
Oct 27, 2015
FIERCE MEDICAL DEVICES
Cardionomic: NEA, Cleveland Clinic, Greatbatch back $20M Series A for neuromodulation heart failure startup
Oct 27, 2015
MINNEAPOLIS ST.PAUL BUSINESS JOURNAL
Cardionomic: Cardionomic raises $20M in big VC debut
Oct 27, 2015
MASS DEVICE
Cardionomic: HF neurmod developer Cardionomic nets $20m in Series A
